Financhill
Back

Alaunos Therapeutics Stock Predictions

Alaunos Therapeutics Stock Forecast

  • Is Alaunos Therapeutics Stock Undervalued?
    The current Alaunos Therapeutics [TCRT] share price is $2.39. The Score for TCRT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • TCRT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Alaunos Therapeutics Stock Go Up Next Year?

Data Unavailable

Alaunos Therapeutics Stock Rating

Data Unavailable

Alaunos Therapeutics Stock Price History

Is TCRT stock going to rise?

  • The current trend is relatively stagnant and TCRT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alaunos.com

52-Week Data

52-Week High:
32.85
52-Week Low:
1.95

Prediction Charts

Market Cap:
3.83M
Price in USD:
2.39
Volume:
7.13K
Beta:
0.96

Technical Analysis

SMA50:
2.45
SMA100:
2.99
SMA200:
8.54
52-Wk Change:
-74.79%

Stock Predictions

  • Is Alaunos Therapeutics stock public?
    Yes, Alaunos Therapeutics is a publicly traded company.
  • What is the Alaunos Therapeutics stock quote today?
    The Alaunos Therapeutics stock price is 2.39 USD today.
  • How to buy Alaunos Therapeutics stock online?
    You can buy Alaunos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 2.01 2.04 2.07 2.01
Nov-6 2.04 2.16 2.17 2.02
Nov-7 2.08 2.02 2.12 2.02
Nov-8 2.02 1.98 2.02 1.95
Nov-11 1.95 2.10 2.15 1.95
Nov-12 2.14 2.44 2.44 2.14
Nov-13 2.41 2.40 2.86 2.40
Nov-14 2.38 2.34 2.59 2.30
Nov-15 2.41 2.09 2.41 2.07
Nov-18 2.10 2.14 2.29 2.10
Nov-19 2.14 2.11 2.27 2.11
Nov-20 2.15 2.13 2.38 2.07
Nov-21 2.15 2.32 2.34 2.15
Nov-22 2.31 2.39 2.44 2.30

Alaunos Therapeutics Earnings

Data Unavailable

Alaunos Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $21.90 per share, and a decrease next year of $1.35 per share.

* Alaunos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.